Network origin in Ganesh Raghu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ganesh Raghu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Investment Managers | Director of Finance/CFO Director/Board Member | |
| Vero Biotech, Inc. | Director/Board Member Chief Executive Officer | ||
Interward Asset Management Ltd.
 Interward Asset Management Ltd. Investment ManagersFinance Interward Asset Management, Ltd. (IAML) is a Canadian multi-family office headquartered in Toronto, Ontario. The firm was founded by Kim Ward in 1990. IAML serves a discrete number of high-net-worth clients focused on private and public equities. | Investment Managers | Analyst-Equity | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University At Buffalo | College/University | Doctorate Degree | |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Private Equity Investor | |
| Kennesaw State University | College/University | Undergraduate Degree | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cardiorentis AG
 Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | President | |
| Mercer University | College/University | Masters Business Admin | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| University of Western Ontario | College/University | Undergraduate Degree | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| COCRYSTAL PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Schulich School of Business | College/University | Masters Business Admin | |
Tyrogenex, Inc.
 Tyrogenex, Inc. Pharmaceuticals: MajorHealth Technology Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Director/Board Member | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree |
Statistics
International
| United States | 19 |
| Canada | 4 |
| Switzerland | 2 |
Sectoral
| Health Technology | 14 |
| Consumer Services | 7 |
| Finance | 3 |
Operational
| Director/Board Member | 16 |
| Undergraduate Degree | 4 |
| Independent Dir/Board Member | 3 |
| Private Equity Investor | 3 |
| President | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Todd Brady | 15 |
| Brent Furse | 7 |
| Daniel Salazar | 5 |
| David Stocker | 1 |
- Stock Market
- Insiders
- Ganesh Raghu
- Company connections
